Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05165368 · ClinicalTrials.gov registry record · NA
Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy
A NA study of Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation), sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT05165368: Completed NA study of Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation), sponsored by Loma Linda University.
NCT05165368 is a NA study of Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation) that has completed, run by Loma Linda University. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05165368, a NA study of Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation), has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to compare the effectiveness of providing dietary education to complement Intraneural Facilitation® Therapy (INF® Therapy) (a physical therapy technique being evaluated that may help improve circulation) versus INF® Therapy only in adults with a type of neuropathy called distal symmetric polyneuropathy (DSPN).
Primary Outcome
The Neuropad® test measures sweat production as an indicator for peripheral neuropathy severity in people with type 2 diabetes. Sudometrics image analysis software will be utilized to analyze Neuropad® time to color change since it produces continuous outputs to quantify neuropathic severity.
Conditions Studied
Interventions
- OTHER Intraneural Facilitation® Therapy (INF® Therapy)
- OTHER INF® Therapy
Study Locations (1)
California
- Loma Linda University Health - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2025-05-20 |
| Phase | NA |
What the finished NCT05165368 record still lists
NCT05165368 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation) appearing as the primary indexed condition, and to 2 interventions - of which Intraneural Facilitation® Therapy (INF® Therapy) is the first listed.
NCT05165368 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05165368 about?
NCT05165368 is a clinical study titled "Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy". The purpose of this research is to compare the effectiveness of providing dietary education to complement Intraneural Facilitation® Therapy (INF® Therapy) (a physical therapy technique being evaluated that may help improve circulation) versus INF® Therapy only in adults with a type of neuropathy cal...
What is the current status of trial NCT05165368?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2023-08-01. Estimated completion is 2025-05-20.
What conditions does trial NCT05165368 study?
This clinical trial studies the following conditions: Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation).
What interventions are being tested in trial NCT05165368?
The interventions under investigation include: Intraneural Facilitation® Therapy (INF® Therapy) (OTHER), INF® Therapy (OTHER).
Who is sponsoring clinical trial NCT05165368?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05165368 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05165368's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI